跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,845 条关于
“CLR-225”
全部
10,845
临床试验
5,566
药物
3,001
机构
33
资讯
2,245
9个月前
Cellectar Biosciences Secures Multi-Year Supply Agreement for Alpha-Emitting Radioisotopes to Advance Targeted Cancer Therapies
8个月前
Cellectar Biosciences Advances Iopofosine I 131 Toward European Approval for Waldenström's Macroglobulinemia
去年
Cellectar Biosciences Raises $2.5 Million Through Warrant Exercise to Advance Cancer Drug Development
去年
Cellectar Biosciences to Pursue Strategic Options for Iopofosine I 131, Prioritizes Solid Tumor Radiotherapies
去年
Cellectar Biosciences Submits Phase 1b Protocol for CLR 125 Radiopharmaceutical in Triple-Negative Breast Cancer
11个月前
Cellectar Biosciences Raises $5.8 Million Through Warrant Exercise to Advance Cancer Drug Pipeline
11个月前
Cellectar Partners with Evestia Clinical for Phase 1b Trial of CLR 125 Radiopharmaceutical in Triple-Negative Breast Cancer
去年
Cellectar Biosciences Advances Iopofosine I 131 and Radioconjugate Pipeline at Biotech Showcase
去年
TerraPower Isotopes Commercially Produces Actinium-225 for Targeted Cancer Therapies
去年
Eckert & Ziegler and GlyTherix Expand Collaboration with Actinium-225 Supply Agreement
第 1 页,共 225 页
上一页
下一页